Showing results (111-120 of 3,921) with videos related to

Sort By:
Pageof 393
European Journal of Gynaecological Oncology|June 9, 2015
Expression of estrogen receptors in melanoma and sentinel lymph nodes; a "female" clinical entity or a possible treatment modality?C Spyropoulos, M Melachrinou, P Vasilakos, et al.
European Journal of Gynaecological Oncology|June 9, 2015
Clinical significance of ASCUS and ASC-H cytological abnormalities: a six-year experience at a single centerG S Demirtas, L Akman, O Demirtas, et al.
European Journal of Gynaecological Oncology|June 9, 2015
Disease-free ovarian cancer patients report severe pain and fatigue over time: prospective quality of life assessment in a consecutive seriesS Shinde, T Wanger, P Novotny, et al.
European Journal of Gynaecological Oncology|June 9, 2015
Angioleiomyoma of the uterus: report of a distinctive benign leiomyoma variantA Zizi-Sermpetzoglou, D Myoteri, E Arkoumani, et al.
European Journal of Gynaecological Oncology|June 9, 2015
Metastases of renal clear cell carcinoma to ovary--case report and review of the literatureM Kostrzewa, M Zyła, J Władziński, et al.
European Journal of Gynaecological Oncology|January 1, 1989
Complications of uterine cervix treatments: proposal for a glossary for a uniform classificationP Sismondi, P Zola, G Sinistrero, et al.
European Journal of Gynaecological Oncology|March 23, 2007
Immunoreactivities of human nonmetastatic clone 23 and p53 products are disassociated and not good predictors of lymph node metastases in early-stage cervical cancer patientsY T Tee, P H Wang, J L Ko, et al.
European Journal of Gynaecological Oncology|January 1, 1991
Pretreatment serum levels of C-reactive protein, alpha 1-antitrypsin, haptoglobin, alpha 1-acid glycoprotein and tissue polypeptide antigen in cervical carcinomaE Avall Lundqvist, E Blad, L Xiao, et al.
European Journal of Gynaecological Oncology|June 28, 2006
Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia (CIN), but not with high-risk human papillomavirus (HPV) or disease outcome in cervical cancerM Branca, C Giorgi, M Ciotti, et al.
European Journal of Gynaecological Oncology|June 28, 2006
Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk cervical cancer: long-term follow-upP A Argenta, R Ghebre, K E Dusenbery, et al.
Pageof 393